The Journal of Biopharmaceutical Statistics, a rapid publication journal, discusses quality applications of statistics in biopharmaceutical research and development. Now publishing six times per year, it includes expositions of statistical methodology with immediate applicability to such work in the form of full-length and short manuscripts, review articles, selected/invited conference papers, short articles, and letters to the editor. Addressing timely and provocative topics important to the biostatistical profession, the journal covers:

• drug, device, and biological research and development
• drug screening and drug design
• assessment of pharmacological activity
• pharmaceutical formulation and scale-up
• preclinical safety assessment
• bioavailability, bioequivalence, and pharmacokinetics
• phase, I, II, and III clinical development
• premarket approval assessment of clinical safety
• postmarketing surveillance

Publication office: Taylor & Francis, Inc., 325 Chestnut Street, Suite 800, Philadelphia, PA 19106.